Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00381030 · ClinicalTrials.gov registry record · Phase 4
Effects of Carvedilol on Health Outcomes in Heart Failure
A Phase 4 study of Heart Failure, Congestive, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT00381030: Completed Phase 4 study of Heart Failure, Congestive, sponsored by Denver Health and Hospital Authority.
NCT00381030 is a Phase 4 study of Heart Failure, Congestive that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 100 participants, below the 672-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00381030, a Phase 4 study of Heart Failure, Congestive, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of our study was to determine if a strategy of starting a heart medication (Beta-blocker) before patients leave the hospital and then being seen by a nurse manager would reduce subsequent hospitalizations compared to usual care. Hypothesis: A nurse-directed heart failure management program with inpatient initiation of beta blockers will improve health outcomes in a vulnerable, predominantly Hispanic and African American population.
Conditions Studied
Interventions
- DRUG carvedilol plus nurse management
Study Locations (1)
Colorado
- Denver Health Medical Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2002-10 |
| Est. Completion | 2005-03 |
| Phase | Phase 4 |
What the finished NCT00381030 record still lists
NCT00381030 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 672-participant average among 39 other Heart Failure, Congestive trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Heart Failure, Congestive appearing as the primary indexed condition, and to 1 intervention - of which carvedilol plus nurse management is the first listed.
NCT00381030 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT00381030 about?
NCT00381030 is a clinical study titled "Effects of Carvedilol on Health Outcomes in Heart Failure". The purpose of our study was to determine if a strategy of starting a heart medication (Beta-blocker) before patients leave the hospital and then being seen by a nurse manager would reduce subsequent hospitalizations compared to usual care. Hypothesis: A nurse-directed heart failure management prog...
What is the current status of trial NCT00381030?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2002-10. Estimated completion is 2005-03.
What conditions does trial NCT00381030 study?
This clinical trial studies the following conditions: Heart Failure, Congestive.
What interventions are being tested in trial NCT00381030?
The interventions under investigation include: carvedilol plus nurse management (DRUG).
Who is sponsoring clinical trial NCT00381030?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00381030 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure, Congestive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00381030's enrollment target sits among peer trials
100 24th of 39 higher than 16 of 39 other Heart Failure, Congestive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure, Congestive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
RECRUITING · Phase 4
-
Exercise Effect on Aerobic Capacity and QOL in Heart Failure
COMPLETED · Phase 4
-
Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
COMPLETED · Phase 4
-
The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure
COMPLETED · Phase 4
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia